The prognostic value of PSA levels in radiation therapy of patients with carcinoma of the prostate: the UCLA experience 1988-1992.

@article{Schneider1996ThePV,
  title={The prognostic value of PSA levels in radiation therapy of patients with carcinoma of the prostate: the UCLA experience 1988-1992.},
  author={Susanne B. Schneider and V G Schweitzer and Robert Gary Parker and P W Bycott},
  journal={American journal of clinical oncology},
  year={1996},
  volume={19 1},
  pages={
          65-72
        }
}
BACKGROUND AND OBJECTIVES Pretreatment prostate-specific antigen (PSA) levels may be of prognostic significance for patients with prostate cancer. Posttreatment PSA data are more limited. This study was undertaken to examine the prognostic role of pretreatment and posttreatment PSA levels in the radiation treatment of patients with carcinoma of the prostate. METHODS One hundred one patients who received primary radiation therapy at UCLA between 1988 and 1992 for clinical stage A to D1… CONTINUE READING